We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Robotic-Assisted Prostate Surgery Outcomes Improve with Practice

By HospiMedica International staff writers
Posted on 21 Jan 2014
A new study shows that robot-assisted radical prostatectomy (RARP) in the hands of skilled surgeons result in a shorter average hospital stay and lower overall complication rate.

Researchers at the MD Anderson Cancer Center (Houston, TX, USA) conducted a large, population-based study to assess the learning curve effect of RARP, and to compare the results to open radical prostatectomy (ORP) in the same settings. More...
The patient population for the study was from the Premier Perspective database, and consisted of 71,312 procedures performed at 300 hospitals by 3,739 surgeons between 2004 and 2010; pretreatment comorbidity profiles were similar in all cohorts. The key endpoints were surgery time, inpatient length of stay, and overall complications.

The results showed that mean surgery time was longer for RARP (4.4 hours) compared to ORP (3.4 hours) in the same hospitals, but inpatient stay was shorter for RARP (2.2 days) compared to ORP (3.2 days). The overall complication rate for RARP (10.6%) was less than that for ORP (15.8%), as were transfusion rates. ORP results in hospitals without a robot were not better than ORP with a robot. Trending of results by year of procedure showed no differences in the three cohorts, but trending of RARP results by surgeon experience showed improvements in surgery time, hospital stay, conversion rates, and complication rates. The study was published in the December 18, 2013, electronic edition of the Journal of Endourology.

“During the initial seven years of RARP development, outcomes showed decreased hospital stay, complications, and transfusion rates. Learning curve trends for RARP were evident for these endpoints when grouped by surgeon experience, but not by year of surgery,” concluded lead author John W. Davis, MD, and colleagues. “Our analysis shows that outcomes of robotic-assisted radical prostatectomy improve as surgeons gain more experience with the procedure, and generally can be favorable relative to open surgery.”

The goal of radical prostatectomy is to excise the cancer completely, provide good urinary continence postoperatively, and maintain the ability to have erections after the surgery (if present before the surgery). RARP is performed with the assistance of a surgical robot, which duplicates the standard retropubic ORP, but with smaller incisions. Through these incisions are passed a camera, two robotic manipulating arms, and two assisting instruments. The surgeon sits at a console and manipulates the robot arms and camera with hand-controls, while looking at the operative field with an immersive 3-dimensional (3D) view. The advantages of RARP include improved cosmetic result, less blood loss, and briefer and less intense postoperative convalescence.

Related Links:

MD Anderson Cancer Center



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.